Update of the Belgian regulatory guidance on the use of GMOs in clinical trials

The FAMHP and Sciensano are making available a Belgian regulatory guidance on the use of genetically modified organisms in clinical trials.

This guidance provides a complete overview of the legal procedures in Belgium for submitting a dossier for a clinical trial involving a GMO. It also presents the deadlines associated with these procedures and the authorities involved.